Last synced on 17 January 2025 at 11:05 pm

Intravenous Catheter Force-Activated Separation Device.

Page Type
Product Code
Definition
An intravenous (IV) catheter force-activated separation device. An intravenous catheter force-activated separation device is placed inline with an intravenous catheter and an intravascular administration set, including any administration set accessories. It separates into two parts when a specified force is applied. The device is intended to reduce the risk of IV catheter failure(s) requiring IV catheter replacement.
Physical State
The device allows fluid flow when intact. Once separated, valves inside the device close and stop fluid flow.
Technical Method
Separates when a specified force is exerted on an intravascular administration set that stops fluid flow from the IV administration set and blood flow from the IV catheter. The luer ends of the device may be compliant with ISO 80369-7, Small-bore connectors for liquids and gases in healthcare applications — Part 7: Connectors for intravascular or hypodermic applications or ISO 594-1, Conical fittings with a 6 % (Luer) taper for syringes, needles and certain other medical equipment - Part 1: General requirements or ISO 594-2, Conical fittings with 6 % (Luer) taper for syringes, needles and certain other medical equipment — Part 2: Lock fittings.
Target Area
Indirect contact to peripheral intravenous system.
Regulation Medical Specialty
General Hospital
Review Panel
General Hospital
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
880.5220
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 880.5220 Intravenous catheter force-activated separation device

§ 880.5220 Intravenous catheter force-activated separation device.

(a) Identification. An intravenous catheter force-activated separation device is placed in-line with an intravenous (IV) catheter and an intravascular administration set, including any administration set accessories. It separates into two parts when a specified force is applied. The device is intended to reduce the risk of IV catheter failure(s) requiring IV catheter replacement.

(b) Classification. Class II (special controls). The special controls for this device are:

(1) Performance data must be provided to demonstrate clinically acceptable performance for the intended use of the device.

(2) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested:

(i) Separation force testing;

(ii) Validation of anti-reconnect features;

(iii) Air and liquid leakage testing, both before and after separation;

(iv) Luer connection testing;

(v) Flow rate testing;

(vi) Particulate testing; and

(vii) Microbial ingress testing.

(3) The device must be demonstrated to be biocompatible.

(4) Performance testing must demonstrate that the device is sterile and non-pyrogenic.

(5) Performance testing must support the shelf life of the device by demonstrating continued sterility and device functionality over the identified shelf life.

(6) Device labeling must include:

(i) Instructions for use; and

(ii) A discussion of catheter dressings intended to be used with the device.

[89 FR 66560, Aug. 16, 2024]

Intravenous Catheter Force-Activated Separation Device.

Page Type
Product Code
Definition
An intravenous (IV) catheter force-activated separation device. An intravenous catheter force-activated separation device is placed inline with an intravenous catheter and an intravascular administration set, including any administration set accessories. It separates into two parts when a specified force is applied. The device is intended to reduce the risk of IV catheter failure(s) requiring IV catheter replacement.
Physical State
The device allows fluid flow when intact. Once separated, valves inside the device close and stop fluid flow.
Technical Method
Separates when a specified force is exerted on an intravascular administration set that stops fluid flow from the IV administration set and blood flow from the IV catheter. The luer ends of the device may be compliant with ISO 80369-7, Small-bore connectors for liquids and gases in healthcare applications — Part 7: Connectors for intravascular or hypodermic applications or ISO 594-1, Conical fittings with a 6 % (Luer) taper for syringes, needles and certain other medical equipment - Part 1: General requirements or ISO 594-2, Conical fittings with 6 % (Luer) taper for syringes, needles and certain other medical equipment — Part 2: Lock fittings.
Target Area
Indirect contact to peripheral intravenous system.
Regulation Medical Specialty
General Hospital
Review Panel
General Hospital
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
880.5220
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 880.5220 Intravenous catheter force-activated separation device

§ 880.5220 Intravenous catheter force-activated separation device.

(a) Identification. An intravenous catheter force-activated separation device is placed in-line with an intravenous (IV) catheter and an intravascular administration set, including any administration set accessories. It separates into two parts when a specified force is applied. The device is intended to reduce the risk of IV catheter failure(s) requiring IV catheter replacement.

(b) Classification. Class II (special controls). The special controls for this device are:

(1) Performance data must be provided to demonstrate clinically acceptable performance for the intended use of the device.

(2) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested:

(i) Separation force testing;

(ii) Validation of anti-reconnect features;

(iii) Air and liquid leakage testing, both before and after separation;

(iv) Luer connection testing;

(v) Flow rate testing;

(vi) Particulate testing; and

(vii) Microbial ingress testing.

(3) The device must be demonstrated to be biocompatible.

(4) Performance testing must demonstrate that the device is sterile and non-pyrogenic.

(5) Performance testing must support the shelf life of the device by demonstrating continued sterility and device functionality over the identified shelf life.

(6) Device labeling must include:

(i) Instructions for use; and

(ii) A discussion of catheter dressings intended to be used with the device.

[89 FR 66560, Aug. 16, 2024]